A. Hot
Lyon 1 Université · 425 works · 7,003 citations · h-index 48
Top works
- Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry
- The Systemic Capillary Leak Syndrome: A Case Series of 28 Patients From a European Registry
- Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg–Strauss)
- Adult-Onset Still Disease
- Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies
- Systemic lupus erythematosus-associated acute transverse myelitis: manifestations, treatments, outcomes, and prognostic factors in 20 patients
- Reactive Hemophagocytic Syndrome in Adult-Onset Still Disease
- Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients
- VEXAS syndrome in a woman
- Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections
- Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome
- Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes
- Angioimmunoblastic T-Cell Lymphoma
- Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: Data from the French Autoimmunity and Rituximab registry
- Yield of Bone Marrow Examination in Diagnosing the Source of Fever of Unknown Origin
- Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients
- Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler's syndrome: A french multicenter study
- Long‐Term Followup of a Multicenter Cohort of 101 Patients With Eosinophilic Granulomatosis With Polyangiitis (Churg‐Strauss)
- Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia
- Combination of IL-17 and TNFα induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells